Back to search results
NCT06273982

Behavioral Telehealth in Low-resource Primary Care Settings for Anxiety and Depression in Youth

Enrolling by Invitation
NAAges 8–16InterventionalTreatment
San Diego State University
~220 participants
Updated 2026-04-13 on ClinicalTrials.gov
What's tested:STEP-UP (transdiagnostic behavioral therapy for pediatric anxiety and depression)ARC (assisted referral to community care)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Children's Global Assessment Scale (CGAS)
Measured over Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32)
+2 more outcomes measured

Conditions

Depression, Anxiety

Explore related trials

Generalized Anxiety DisorderPersistent depressive disorderSeparation Anxiety DisorderSocial Anxiety DisorderUnipolar Depression

NCT06273982

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Kaiser Permanente Center for Health Research

    Portland, Oregonno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • V. Robin Weersing, PhD · PRINCIPAL_INVESTIGATOR · San Diego State University
  • Frances Lynch, PhD · PRINCIPAL_INVESTIGATOR · Kaiser Permanente

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Youth is a patient in a participating community health center.
Youths meet criteria for clinically significant anxiety and / or depression as indexed at baseline assessment by either:
research diagnosis of anxiety (Social Anxiety Disorder, Generalized Anxiety Disorder, Separation Anxiety Disorder) and / or depressive disorder (Major Depressive Disorder, Persistent Depressive Disorder).
scores in the clinically elevated range on a standardized anxiety and / or depression symptom measure .
Youth lives with a legal guardian (hereafter referred to as "parent") \>= 50% of the time who consents to study participation.
Youth speaks English.
Parent speaks English or Spanish.

Exclusion

Youth requires alternate treatment as indexed by:
current clinically significant Post-Traumatic Stress Disorder symptoms (meets diagnostic criteria in research interview and / or scores in the clinically elevated range on a standardized symptom measure) at baseline.
current suicidal ideation with plan at baseline and / or suicidal behavior within the last year.
current substance dependence at baseline.
experience of physical or sexual abuse within the six months prior to baseline.
parent /guardian does not identify anxiety and / or depression as a treatment priority at baseline.
Youth is in an active, alternate psychosocial intervention for anxiety or depression that would be concurrent with study participation.
Youth is on an unstable regimen of psychotropic medication (i.e., receives medication but has not been at a stable dose for at least 8 weeks, or if medication has been discontinued for less than 4 weeks) at baseline.
Youth is receiving lithium or and anti-psychotic medication at baseline.
Youth is placed in a special education program for greater than 50% of the school day and / or youth school placement is below the second-grade level at baseline.
Youth is placed in foster care at baseline.

What this trial measures

  • Children's Global Assessment Scale (CGAS)Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32)

    Interviewer-rated youth functioning. Scores range from 1 to 100, and higher score indcate superior functioning.

  • Pediatric Anxiety Rating Scale (PARS)Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The PARS total severity score ranges from 0 to 30, with higher scores indicating greater anxiety severity.

    Interviewer-rated symptoms of anxiety disorders, combining parent and youth report

  • Children's Depression Rating Scale -- Revised (CDRS-R)Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The CDRS-R total severity score ranges from 17 to 113, with higher scores indicating greater depression symptom severity.

    Interviewer rated symptoms of depressive disorders, combining parent and youth report